Extracellular Mediators in Atherosclerosis and Thrombosis
- 1 June 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 23 (6) , 931-939
- https://doi.org/10.1161/01.atv.0000070100.47907.26
Abstract
It is well appreciated that thrombin as well as other proteases can act as signaling molecules that specifically regulate cells by cleaving and activating members of a novel class of protease-activated receptors (PARs). The utility of gene knockout strategies to define and better comprehend the physiological role of specific proteins is perhaps best exemplified in the field of thrombin receptors. The development of PAR knockout mice has provided the unique opportunity to identify and characterize new members of this novel family of GPCRs, evaluate the interaction of PARs jointly expressed in common cells and tissues, and better understand the role of PARs in thrombosis, restenosis, vascular remodeling, angiogenesis, and inflammation. Presently, 4 members of the PAR family have been cloned and identified. In this review, we examine experimental evidence gleaned from PAR−/−mouse models as well as how the use of PAR−/−mice has provided insights toward understanding the physiological role of thrombin in cells of the vascular system and vascular pathology.Keywords
This publication has 70 references indexed in Scilit:
- Coagulation cascade proteases and tissue fibrosisBiochemical Society Transactions, 2002
- Agonists of Proteinase-Activated Receptor 2 Induce Cytokine Release and Activation of Nuclear Transcription Factor κB in Human Dermal Microvascular Endothelial CellsJournal of Investigative Dermatology, 2002
- Agonists of proteinase‐activated receptor 1 induce plasma extravasation by a neurogenic mechanismBritish Journal of Pharmacology, 2001
- Angiogenesis and G-protein-coupled receptors: signals that bridge the gapOncogene, 2001
- Protease-activated receptors: sentries for inflammation?Trends in Pharmacological Sciences, 2000
- Cutaneous Wound HealingNew England Journal of Medicine, 1999
- Protease‐activated receptor‐2 turnover stimulated independently of receptor activation in porcine coronary endothelial cellsBritish Journal of Pharmacology, 1999
- Receptor-activating peptides distinguish thrombin receptor (PAR-1) and protease activated receptor 2 (PAR-2) mediated hemodynamic responses in vivoCanadian Journal of Physiology and Pharmacology, 1998
- Presence of the seven transmembrane thrombin receptor on human tumour cells: effect of activation on tumour adhesion to platelets and tumour tyrosine phosphorylationBritish Journal of Haematology, 1996
- Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activationCell, 1991